東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Nano-biomaterials for ophthalmic dru...

Pathak, Yashwant.

FindBook

Google Book

Amazon

博客來

Nano-biomaterials for ophthalmic drug delivery

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Nano-biomaterials for ophthalmic drug delivery/ edited by Yashwant Pathak, Vijaykumar Sutariya, Anjali A. Hirani.
其他作者:	Pathak, Yashwant.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	xix, 627 p. :ill., digital ;24 cm.
內容註:	Forward -- Preface -- Introduction -- Overview of the Ophthalmic System -- Pharmacological Considerations in Ophthalmic Drug Delivery -- Pathophysiology of Vision -- Nanotechnology and Nanomaterials in Ophthalmic Drug Delivery -- Pharmacokinetics and Pharmacodynamics of Ocular Drugs -- Physicochemical Requirements for Polymers and Polymer Based Nanomaterial for Ophthalmic Drug Delivery -- Formulation Approaches for Ocular Drug Delivery -- Ocular Permeation Enhancers -- Ocular Bioadhesives and their Applications in Ophthalmic Drug Delivery -- Nano Vesicular Carrier Systems for Ophthalmic Drug Delivery -- Cyclodextrins in Ocular Drug Delivery -- Ocular Preservatives: Risks and Recent Trends in its Application in Ocular Drug Delivery (ODD) -- Ageing Disorders of The Eye: Challenges and Approaches for their Treatment -- Colloidal Carriers in Ophthalmic Drug Delivery -- Polymeric Nanoparticulate Systems: A potential Approach for Occular Drug Delivery -- Barriers to Glaucoma Drug Delivery and Resolving the Challenges Using Nanotechnology -- Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye -- Animal Models to Evaluate Nanoparticulate Ocular Drug Delivery Systems -- Ophthalmic Nanosuspensions: Toxicity and Formulation -- Ocular Drug Delivery: Impact of In Vitro Cell Culture Models -- Nanotoxicity of Nanobiomaterials in Ocular Systems and its Evaluation -- Nanosystem in Ocular Bioenvironment -- Excipients Utilized for Ophthalmic Drug Delivery Systems -- Ophthalmic Drug Delivery Systems for Treatment of Corneal Diseases -- Challenges in Ocular Pharmacokinetics and Drug Delivery.
Contained By:	Springer eBooks
標題:	Drug delivery systems. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-29346-2
ISBN:	9783319293462

Nano-biomaterials for ophthalmic drug delivery
Nano-biomaterials for ophthalmic drug delivery[electronic resource] /edited by Yashwant Pathak, Vijaykumar Sutariya, Anjali A. Hirani. - Cham :Springer International Publishing :2016. - xix, 627 p. :ill., digital ;24 cm.

Forward -- Preface -- Introduction -- Overview of the Ophthalmic System -- Pharmacological Considerations in Ophthalmic Drug Delivery -- Pathophysiology of Vision -- Nanotechnology and Nanomaterials in Ophthalmic Drug Delivery -- Pharmacokinetics and Pharmacodynamics of Ocular Drugs -- Physicochemical Requirements for Polymers and Polymer Based Nanomaterial for Ophthalmic Drug Delivery -- Formulation Approaches for Ocular Drug Delivery -- Ocular Permeation Enhancers -- Ocular Bioadhesives and their Applications in Ophthalmic Drug Delivery -- Nano Vesicular Carrier Systems for Ophthalmic Drug Delivery -- Cyclodextrins in Ocular Drug Delivery -- Ocular Preservatives: Risks and Recent Trends in its Application in Ocular Drug Delivery (ODD) -- Ageing Disorders of The Eye: Challenges and Approaches for their Treatment -- Colloidal Carriers in Ophthalmic Drug Delivery -- Polymeric Nanoparticulate Systems: A potential Approach for Occular Drug Delivery -- Barriers to Glaucoma Drug Delivery and Resolving the Challenges Using Nanotechnology -- Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye -- Animal Models to Evaluate Nanoparticulate Ocular Drug Delivery Systems -- Ophthalmic Nanosuspensions: Toxicity and Formulation -- Ocular Drug Delivery: Impact of In Vitro Cell Culture Models -- Nanotoxicity of Nanobiomaterials in Ocular Systems and its Evaluation -- Nanosystem in Ocular Bioenvironment -- Excipients Utilized for Ophthalmic Drug Delivery Systems -- Ophthalmic Drug Delivery Systems for Treatment of Corneal Diseases -- Challenges in Ocular Pharmacokinetics and Drug Delivery.

This consolidated reference book addresses the various aspects of nano biomaterials used in ophthalmic drug delivery, including their characterization, interactions with ophthalmic system and applications in treatments of the ophthalmic diseases and disorders. In the last decade, a significant growth in polymer sciences, nanotechnology and biotechnology has resulted in the development of new nano- and bioengineered nano-bio-materials. These are extensively explored as drug delivery carriers as well as for implantable devices and scaffolds. At the interface between nanomaterials and biological systems, the organic and synthetic worlds merge into a new science concerned with the safe use of nanotechnology and nano material design for biological applications. For this field to evolve, there is a need to understand the dynamic forces and molecular components that shape these interactions. While it is impossible to describe with certainty all the bio physicochemical interactions at play at the interface, we are at a point where the pockets of assembled knowledge are providing a conceptual framework to guide this exploration, and review the impact on future product development. The book is intended as a valuable resource for academics and pharmaceutical scientists working in the field of polymers, polymers materials for drug delivery, drug delivery systems and ophthalmic drug delivery systems, in addition to medical and health care professionals in these areas.

ISBN: 9783319293462

Standard No.: 10.1007/978-3-319-29346-2doiSubjects--Topical Terms:

657987
Drug delivery systems.

LC Class. No.: RS199.5

Dewey Class. No.: 615.6

Nano-biomaterials for ophthalmic drug delivery
LDR:04107nmm a2200313 a 4500 001 2080489
003 DE-He213
005 20161112075414.0
006 m d
007 cr nn 008maaau
008 170616s2016 gw s 0 eng d
020 $a 9783319293462 $q (electronic bk.)
020 $a 9783319293448 $q (paper)
024 7 $a 10.1007/978-3-319-29346-2 $2 doi
035 $a 978-3-319-29346-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RS199.5
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
082 0 4 $a 615.6 $2 23
090 $a RS199.5 $b .N186 2016
245 0 0 $a Nano-biomaterials for ophthalmic drug delivery $h [electronic resource] / $c edited by Yashwant Pathak, Vijaykumar Sutariya, Anjali A. Hirani.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xix, 627 p. : $b ill., digital ; $c 24 cm.
505 0 $a Forward -- Preface -- Introduction -- Overview of the Ophthalmic System -- Pharmacological Considerations in Ophthalmic Drug Delivery -- Pathophysiology of Vision -- Nanotechnology and Nanomaterials in Ophthalmic Drug Delivery -- Pharmacokinetics and Pharmacodynamics of Ocular Drugs -- Physicochemical Requirements for Polymers and Polymer Based Nanomaterial for Ophthalmic Drug Delivery -- Formulation Approaches for Ocular Drug Delivery -- Ocular Permeation Enhancers -- Ocular Bioadhesives and their Applications in Ophthalmic Drug Delivery -- Nano Vesicular Carrier Systems for Ophthalmic Drug Delivery -- Cyclodextrins in Ocular Drug Delivery -- Ocular Preservatives: Risks and Recent Trends in its Application in Ocular Drug Delivery (ODD) -- Ageing Disorders of The Eye: Challenges and Approaches for their Treatment -- Colloidal Carriers in Ophthalmic Drug Delivery -- Polymeric Nanoparticulate Systems: A potential Approach for Occular Drug Delivery -- Barriers to Glaucoma Drug Delivery and Resolving the Challenges Using Nanotechnology -- Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye -- Animal Models to Evaluate Nanoparticulate Ocular Drug Delivery Systems -- Ophthalmic Nanosuspensions: Toxicity and Formulation -- Ocular Drug Delivery: Impact of In Vitro Cell Culture Models -- Nanotoxicity of Nanobiomaterials in Ocular Systems and its Evaluation -- Nanosystem in Ocular Bioenvironment -- Excipients Utilized for Ophthalmic Drug Delivery Systems -- Ophthalmic Drug Delivery Systems for Treatment of Corneal Diseases -- Challenges in Ocular Pharmacokinetics and Drug Delivery.
520 $a This consolidated reference book addresses the various aspects of nano biomaterials used in ophthalmic drug delivery, including their characterization, interactions with ophthalmic system and applications in treatments of the ophthalmic diseases and disorders. In the last decade, a significant growth in polymer sciences, nanotechnology and biotechnology has resulted in the development of new nano- and bioengineered nano-bio-materials. These are extensively explored as drug delivery carriers as well as for implantable devices and scaffolds. At the interface between nanomaterials and biological systems, the organic and synthetic worlds merge into a new science concerned with the safe use of nanotechnology and nano material design for biological applications. For this field to evolve, there is a need to understand the dynamic forces and molecular components that shape these interactions. While it is impossible to describe with certainty all the bio physicochemical interactions at play at the interface, we are at a point where the pockets of assembled knowledge are providing a conceptual framework to guide this exploration, and review the impact on future product development. The book is intended as a valuable resource for academics and pharmaceutical scientists working in the field of polymers, polymers materials for drug delivery, drug delivery systems and ophthalmic drug delivery systems, in addition to medical and health care professionals in these areas.
650 0 $a Drug delivery systems. $3 657987
650 0 $a Ophthalmic drugs. $3 916270
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Pharmaceutical Sciences/Technology. $3 1001579
650 2 4 $a Biotechnology. $3 571461
650 2 4 $a Ophthalmology. $3 862704
700 1 $a Pathak, Yashwant. $3 1359873
700 1 $a Sutariya, Vijaykumar. $3 3200409
700 1 $a Hirani, Anjali A. $3 3200410
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-29346-2
950 $a Biomedical and Life Sciences (Springer-11642)